LGVN FY 2020 Earnings — Longeveron Inc. Revenue & Financial Results | Market Cap Arena

LGVNLongeveron Inc.

$18M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M-0.0% YoY

Gross Profit

$2M32.4% margin

Operating Income

-$4M-67.1% margin

Net Income

-$4M-66.1% margin

EPS (Diluted)

$-2.21

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$3M

Stock-Based Comp.

$83,000

Balance Sheet

Total Assets

$9M

Total Liabilities

$7M

Stockholders' Equity

$2M

Cash & Equivalents

$816,000

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$6M	-0.0%
Gross Profit	$2M	$2M	-0.0%
Operating Income	-$4M	-$4M	+0.0%
Net Income	-$4M	-$4M	-0.0%